PI
IBER

PEAK6 Investments’s Ibere Pharmaceuticals IBER Stock Holding History

PEAK6 Investments’s Portfolio IBER Stock Details IBER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$496K – 5468
2022
Q3 		$496K Hold
50,000
– – ﹤0.01% 2886
2022
Q2 		$490K Hold
50,000
– – ﹤0.01% 3852
2022
Q1 		$490K Hold
50,000
– – ﹤0.01% 3159
2021
Q4 		$486K Hold
50,000
– – ﹤0.01% 3241
2021
Q3 		$484K Hold
50,000
– – ﹤0.01% 3293
2021
Q2 		$484K Buy
+50,000
New +$487K ﹤0.01% 3261

Other funds holding IBER

GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FTCM
First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

PEAK6 Investments's IBER Position: Q4 2022 in Review

PEAK6 Investments sold out of Ibere Pharmaceuticals (IBER) in Q4 2022, closing a stake of 50,000 shares — an estimated $496K sold.

PEAK6 Investments first reported a position in IBER in Q2 2021 and held it in 6 quarters. The position peaked at $496K in Q3 2022. 47 funds tracked by Wall St. Rank hold IBER as of Q4 2022.

  • PEAK6 Investments reported no remaining Ibere Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • PEAK6 Investments sold 50,000 Ibere Pharmaceuticals shares in Q4 2022, an estimated $496K.
  • PEAK6 Investments first reported a position in Ibere Pharmaceuticals in Q2 2021 and held it in 6 quarters.
  • PEAK6 Investments's Ibere Pharmaceuticals position peaked at $496K in Q3 2022.
  • 47 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q4 2022.

Based on PEAK6 Investments's 13F filing for Q4 2022, filed 10 Feb 2023.